29 March 2026 in Otolaryngology–Head and Neck Surgery
Objective: Comorbid depression is a significant negative predictor of survival in patients with head and neck cancer (HNC). Prior studies have shown a prevalence of up to 40.1%; however, depression is often underdiagnosed in this patient population. Study Design: Retrospective cohort. Setting: Single‐institution database. Methods: Patients who underwent free flap reconstruction for HNC at our institution (January 2019‐December 2023) were retrospectively reviewed. The primary outcome was overall survival (OS). Secondary outcomes included length of stay, discharge disposition, 30‐day readmissions, and postoperative radiotherapy (PORT) delay. Kaplan‐Meier and multivariate Cox proportional hazards models estimated the effect of preoperative depression on OS. Multivariate regression models examined the association of preoperative depression with secondary outcomes. Results: 645 patients were included. Preoperative depression was present in 158 patients (24%) and 150 patients (23%) were on preoperative antidepressants. There was no difference in OS in depressed patients compared to nondepressed patients (adjusted hazard ratio [aHR] 1.07, 95% confidence interval [CI] 0.76‐1.51). Preoperative antidepressant use was independently associated with discharge to rehabilitation or skilled nursing facilities compared to discharge home (adjusted odds ratio [aOR] 1.82, 95% CI 1.07‐3.06). There were no associations of preoperative depression with length of stay, 30‐day readmission rates, or PORT delay. Conclusion: Preoperative antidepressant use is associated with greater likelihood of discharge to rehabilitation facilities after free flap reconstruction. Preoperative depression was present at one‐half the estimated rate in our patients, highlighting the need for improved preoperative screening and intervention.
22 February 2025 in The Laryngoscope
24 May 2025 in Laryngoscope Investigative Otolaryngology
Objective: ENE is an important prognostic factor in p16‐positive OPSCC and is an indication for adjuvant chemoradiation. A recent single institution retrospective study demonstrated that core needle biopsy (CNB) was independently associated with ENE, potentially due to disruption of the lymph node capsule. In this study, we investigate the association between the type of preoperative nodal biopsy and ENE at our institution.Study Design: Retrospective cohort study.Methods: Patients with p16‐positive OPSCC who underwent primary surgical resection (transoral robotic surgery and neck dissection) from October 2011 to March 2025 were identified. Univariate logistic regression analysis was performed to determine the association between the type of preoperative biopsy and ENE. The impact of confounding variables was assessed using a multivariate logistic regression model.Results: We identified 123 patients with a mean age of 60.9 years (range 38–80). Sixteen patients underwent preoperative CNB (13.0%), 74 patients underwent preoperative FNA (60.2%), and 33 patients did not undergo preoperative biopsy of a lymph node (26.8%). ENE was present in 43 patients (35.0%) including 7/16 (43.8%) CNB, 28/74 (37.8%) FNA, and 8/33 (27.2%) no preoperative biopsy. CNB was not associated with ENE (univariate OR 2.43, 95% CI 0.68–8.84, multivariate OR 2.34, 95% CI 0.50–11.74). Preoperative CNB was not associated with receipt of adjuvant treatment. Patients who presented with more than one clinically positive lymph node (cN2b) had a 48.6% chance of pathological ENE.Conclusion: In this single institution study of patients with surgically treated p16‐positive OPSCC, preoperative CNB was not associated with ENE.Level of Evidence: Level 4.
26 March 2026 in OTO Open
Objective: To evaluate the impact of histologic origin on survival in salivary duct carcinoma (SDC) and characterize its clinical and pathologic features. Study Design: Retrospective cohort study. Setting: Single, tertiary academic medical center. Methods: This study included treatment‐naïve patients diagnosed with SDC (2000‐2024). Histologic origin (ex pleomorphic adenoma [PA] vs de novo) was determined pathologically or clinically. Kaplan‐Meier analysis and log‐rank tests assessed overall survival (OS) and disease‐free survival (DFS). Cox regression estimated hazard ratios (HR) and 95% confidence intervals (CI) for 13 covariates. Results: Out of N = 85 SDC patients, 68 were treated with curative intent, including 43 de novo and 25 ex PA cases. Median follow‐up was 19.8 months. OS and DFS survival were not significantly different by histologic origin (OS P = .28; DFS P = .19), though 2‐year OS and DFS were numerically higher in ex PA (OS: 87% vs 81%, DFS: 63% vs 57%). Histologic origin was not associated with OS (univariate P = .29) or DFS (univariate P = .19; multivariable P = .23). Distant recurrence was the most common failure pattern, occurring more frequently in de novo cases (37% vs 21%, P = .23). Conclusion: Histologic origin was not independently associated with OS or DFS, although numerically higher 2‐year survival in SDC ex PA may suggest potential biologic differences between ex PA and de novo origins that warrant further study. Distant metastasis was the primary mechanism of treatment failure for both subtypes of SDC, highlighting the need to explore novel treatments, such as neoadjuvant therapies.
16 April 2026 in Otolaryngology–Head and Neck Surgery
Objective: Tissue shrinkage can make planning of surgical margins challenging. While shrinkage of resected oral cavity mucosa is well‐described, current data quantifying these effects are variable. The aim of this systematic review was to summarize current evidence on margin shrinkage in oral cavity cancer after resection and formalin fixation. Data Sources: PubMed, Embase, Web of Science, and Cochrane Database of Systematic Reviews. Review Methods: A systematic review was performed according to PRISMA guidelines to identify all published reports describing margin shrinkage in surgically resected oral cavity cancer. Only prospective cohort and cross‐sectional studies were included. Non‐English language studies, studies on non‐human subjects, and studies describing cancer of sites other than the oral cavity were excluded. Results: Ten studies met inclusion criteria, accounting for 352 patients who underwent resection of oral cavity cancer. Mean percent margin shrinkage from preresection to postresection ranged from 14.9% to 23.9%, from postresection to postfixation ranged from 3.7% to 32.9%, and from preresection to postfixation ranged from 11.3% to 59.0%. In studies reporting preresection, postresection, and postfixation margins (4 studies), preresection to postresection shrinkage was significantly larger than postresection to postfixation shrinkage. There was conflicting evidence on shrinkage by T stage and tumor subsite. There was no association between margin shrinkage and other clinicopathologic factors such as age, sex, or other adverse pathological factors. Conclusion: Oral cavity tissue undergoes shrinkage both after surgical resection and after fixation with formalin, with the most significant shrinkage occurring immediately after resection. Tissue shrinkage should be an important consideration in the planning of surgical margins.
30 April 2026 in Otolaryngology–Head and Neck Surgery
Objective: Head and neck cancer (HNC) surgery is associated with postoperative pain and comorbid mental health disorders (MHDs). This study assessed predictors of postoperative pain and inpatient pain service consultation following free flap reconstruction (FFR). Study Design: Retrospective cohort. Setting: Single‐institution database. Methods: Multivariable linear and logistic regressions identified predictors of postoperative day 5 (POD5) pain scores (0‐10) and pain consultation, respectively. Propensity‐matched analyses compared pain trajectories by MHD (depression or anxiety) and pain consultation. Results: The cohort included 645 FFR patients. Higher POD5 pain was associated with MHD ( β : 0.43; 95% CI: 0.03, 0.84), currently smoking ( β : 0.58; 95% CI: 0.14, 1.03), being separated/divorced versus single ( β : 0.71; 95% CI: 0.03, 1.39), osteocutaneous radial forearm free flap (OCRFFF) versus fasciocutaneous radial forearm free flap (RFFF) ( β : 0.54; 95% CI: 0.02, 1.05), laryngeal site versus oral cavity ( β : 0.59; 95% CI: 0.06, 1.13; P = .029), and non‐oncologic indication ( β : 0.86; 95% CI: 0.06, 1.67; P = .036). Pain consultation was associated with MHD (adjusted odds ratio [aOR]: 1.99; 95% CI: 1.13‐3.52), preoperative narcotic use (aOR: 3.20; 95% CI: 1.77‐5.79), OCRFFF (aOR: 3.42; 95% CI: 1.53‐7.66), and private insurance (aOR: 3.09; 95% CI: 1.46‐6.58). Among propensity‐matched patients with an MHD, pain scores were not significantly different by pain consultation, while non‐MHD patients with pain consultation reported higher pain across POD1‐5 ( P < .01). Conclusion: Psychosocial and clinical factors such as MHD diagnosis were independently associated with pain scores and pain service consultation after FFR. Patients with an MHD are particularly vulnerable. Identifying risk factors preoperatively may guide personalized perioperative pain management strategies.